Market Overview
Hemoglobin A1c (HbA1c) is a form of hemoglobin that is bound to glucose. The HbA1c test provides the patient with the average level of blood sugar only for the past 2 to 3 months. HbA1c Testing Market is anticipated to enroll a CAGR of 12.24% to reach USD 1,992.44 Million by 2025.
Market Dynamics
In general, diabetes has become one of the most prevalent epidemics across the world, and among the three types of diabetes, type 2 diabetes is the most common. Agreeing to a research paper published by the National Center for Biotechnology Information (NCBI) in September 2016, diabetes is anticipated to be the seventh prominent cause of death by 2030. Moreover, according to data published by the International Diabetes Federation in 2017, the prevalence of diabetes in Brazil was 8.7% among adults and reported 12,465,800 cases of diabetes in 2017.
Request Free Sample copy here: https://www.reportocean.com/industry-verticals/sample-request?report_id=MRF184
Segmentation Overview of the Global HbA1c Testing Market
The Global HbA1c Testing Market is categorized into various segments. These major market segments are further categorized into various sub-segments to study the market in detail. The segmentation study offers detailed market study considering various growth determinants and geographical dynamics.
Global HbA1c Testing Market, by Product
Global HbA1c Testing Market, by Technology
Global HbA1c Testing Market, by End User
Regional Overview of the Global HbA1c testing Market
Geographically the Global HbA1c testing market is split in regions like North & South America, Europe, Asia-Pacific, Middle east and Africa and Rest of the world.
The Americas is likely to dominate the global HbA1c testing market. This can be attributed to growing activities such as research, recognition campaigns, and joint ventures by public and private organizations in the US and Canada.
The European market for HbA1c testing is expected to be the second largest during the review period. Their growing adoption of advanced diagnostic tools and devices coupled with the strategic activities such as relationships and agreements by the prominent players is expected to boost the growth of the regional market.
Asia-Pacific is estimated to be the fastest-growing market owing to the developing healthcare infrastructure and ever-increasing per capita disposable incomes.
The market in the Middle East & Africa is expected to witness steady growth due to limited access to healthcare. The growing awareness regarding healthcare and the availability of new advanced treatment options are factors expected to drive the growth of the market in the region.
HbA1c Testing Market Key Players
The Prominent Players in the Global HbA1c Testing Market are Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), ARKRAY, Inc. (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (US), Siemens Healthineers (US), Transasia Bio-Medicals (India), EKF Diagnostics (UK), Agappe Diagnostics Ltd (India), PTS Diagnostics (US), DiaSys Diagnostic Systems GmbH (Germany), CPC Diagnostics Pvt. Ltd. (India), Trinity Biotech PLC (Ireland), Rapid Diagnostics Group of Companies (India), and Tosoh India Pvt. Ltd. (India).
Request for full Report: https://www.reportocean.com/industry-verticals/sample-request?report_id=MRF184